vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Getty Images Holdings, Inc. (GETY). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $282.3M, roughly 1.0× Getty Images Holdings, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -32.2%, a 128.5% gap on every dollar of revenue. On growth, Getty Images Holdings, Inc. posted the faster year-over-year revenue change (14.1% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 12.7%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
ACAD vs GETY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $282.3M |
| Net Profit | $273.6M | $-90.9M |
| Gross Margin | 90.8% | 74.8% |
| Operating Margin | 6.1% | -8.5% |
| Net Margin | 96.3% | -32.2% |
| Revenue YoY | 9.4% | 14.1% |
| Net Profit YoY | 90.3% | -467.6% |
| EPS (diluted) | $1.61 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $282.3M | ||
| Q3 25 | $278.6M | $240.0M | ||
| Q2 25 | $264.6M | $234.9M | ||
| Q1 25 | $244.3M | $224.1M | ||
| Q4 24 | $259.6M | $247.3M | ||
| Q3 24 | $250.4M | $240.5M | ||
| Q2 24 | $242.0M | $229.1M | ||
| Q1 24 | $205.8M | $222.3M |
| Q4 25 | $273.6M | $-90.9M | ||
| Q3 25 | $71.8M | $21.6M | ||
| Q2 25 | $26.7M | $-34.4M | ||
| Q1 25 | $19.0M | $-102.6M | ||
| Q4 24 | $143.7M | $24.7M | ||
| Q3 24 | $32.8M | $-2.5M | ||
| Q2 24 | $33.4M | $3.7M | ||
| Q1 24 | $16.6M | $13.6M |
| Q4 25 | 90.8% | 74.8% | ||
| Q3 25 | 92.2% | 73.2% | ||
| Q2 25 | 92.2% | 72.1% | ||
| Q1 25 | 91.7% | 73.1% | ||
| Q4 24 | 91.6% | 73.5% | ||
| Q3 24 | 92.5% | 73.4% | ||
| Q2 24 | 92.5% | 72.5% | ||
| Q1 24 | 88.8% | 72.9% |
| Q4 25 | 6.1% | -8.5% | ||
| Q3 25 | 12.8% | 18.8% | ||
| Q2 25 | 12.2% | 15.1% | ||
| Q1 25 | 7.9% | 12.2% | ||
| Q4 24 | 59.1% | 14.5% | ||
| Q3 24 | 12.6% | 23.9% | ||
| Q2 24 | 12.6% | 20.3% | ||
| Q1 24 | 7.4% | 18.5% |
| Q4 25 | 96.3% | -32.2% | ||
| Q3 25 | 25.8% | 9.0% | ||
| Q2 25 | 10.1% | -14.6% | ||
| Q1 25 | 7.8% | -45.8% | ||
| Q4 24 | 55.4% | 10.0% | ||
| Q3 24 | 13.1% | -1.1% | ||
| Q2 24 | 13.8% | 1.6% | ||
| Q1 24 | 8.0% | 6.1% |
| Q4 25 | $1.61 | $-0.22 | ||
| Q3 25 | $0.42 | $0.05 | ||
| Q2 25 | $0.16 | $-0.08 | ||
| Q1 25 | $0.11 | $-0.25 | ||
| Q4 24 | $0.86 | $0.07 | ||
| Q3 24 | $0.20 | $-0.01 | ||
| Q2 24 | $0.20 | $0.01 | ||
| Q1 24 | $0.10 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $90.2M |
| Total DebtLower is stronger | — | $1.3B |
| Stockholders' EquityBook value | $1.2B | $552.5M |
| Total Assets | $1.6B | $3.2B |
| Debt / EquityLower = less leverage | — | 2.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $90.2M | ||
| Q3 25 | $258.0M | $109.5M | ||
| Q2 25 | $253.6M | $110.3M | ||
| Q1 25 | $217.7M | $114.6M | ||
| Q4 24 | $319.6M | $121.2M | ||
| Q3 24 | $155.1M | $109.9M | ||
| Q2 24 | $177.1M | $121.7M | ||
| Q1 24 | $204.7M | $134.2M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $1.2B | $552.5M | ||
| Q3 25 | $917.3M | $634.6M | ||
| Q2 25 | $822.4M | $611.2M | ||
| Q1 25 | $765.2M | $593.0M | ||
| Q4 24 | $732.8M | $670.2M | ||
| Q3 24 | $577.2M | $683.4M | ||
| Q2 24 | $516.7M | $654.0M | ||
| Q1 24 | $464.0M | $640.8M |
| Q4 25 | $1.6B | $3.2B | ||
| Q3 25 | $1.3B | $2.6B | ||
| Q2 25 | $1.2B | $2.6B | ||
| Q1 25 | $1.1B | $2.6B | ||
| Q4 24 | $1.2B | $2.6B | ||
| Q3 24 | $976.9M | $2.6B | ||
| Q2 24 | $914.1M | $2.6B | ||
| Q1 24 | $855.1M | $2.6B |
| Q4 25 | — | 2.30× | ||
| Q3 25 | — | 2.11× | ||
| Q2 25 | — | 2.19× | ||
| Q1 25 | — | 2.21× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 2.06× | ||
| Q1 24 | — | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $20.6M |
| Free Cash FlowOCF − Capex | — | $7.7M |
| FCF MarginFCF / Revenue | — | 2.7% |
| Capex IntensityCapex / Revenue | — | 4.6% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $20.6M | ||
| Q3 25 | $74.3M | $22.6M | ||
| Q2 25 | $64.0M | $6.5M | ||
| Q1 25 | $20.3M | $15.4M | ||
| Q4 24 | $40.4M | $39.7M | ||
| Q3 24 | $63.2M | $10.7M | ||
| Q2 24 | $25.0M | $46.4M | ||
| Q1 24 | $29.1M | $21.5M |
| Q4 25 | — | $7.7M | ||
| Q3 25 | $73.9M | $7.9M | ||
| Q2 25 | — | $-9.6M | ||
| Q1 25 | — | $-322.0K | ||
| Q4 24 | — | $24.6M | ||
| Q3 24 | $63.2M | $-1.8M | ||
| Q2 24 | — | $31.1M | ||
| Q1 24 | — | $7.1M |
| Q4 25 | — | 2.7% | ||
| Q3 25 | 26.5% | 3.3% | ||
| Q2 25 | — | -4.1% | ||
| Q1 25 | — | -0.1% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | 25.2% | -0.8% | ||
| Q2 24 | — | 13.6% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | 4.6% | ||
| Q3 25 | 0.1% | 6.1% | ||
| Q2 25 | — | 6.9% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | 0.0% | 5.2% | ||
| Q2 24 | — | 6.7% | ||
| Q1 24 | — | 6.5% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 1.05× | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | 1.61× | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | 12.59× | ||
| Q1 24 | 1.76× | 1.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
